Metabolic Cardiovascular Syndrome Clinical Trial
Official title:
The Effects of Home Bicycle Exercise Program on Hyperlipidemia, Hypertension, Blood Sugar Control, Muscle Strength and Aerobic Capacity
The subjects with MetS or type 2 diabetes were enrolled for this exercise-training program. All participators underwent an indoor bicycle exercise for twelve weeks. In addition to demographic data and biochemical tests were determined after an overnight fasting. Extension of muscle strength was detected in the dominant lower extremity.
This prospective open-labeled study was conducted in Taichung Veterans General Hospital. The adult participants with metabolic syndrome and/or type 2 diabetes were enrolled. MetS. The procedures were fully explained to all subjects before the cardiopulmonary exercise test. ll enrolled subjects received a scheduled twelve-week program for exercise-training program. A commercially available bicycle with an indoor bicycle trainer are used as the home exercise training modality. All medications were not allowed to be changed during the study. ;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT02077179 -
Health Improvement After Pregnancy (HIP) Program Randomized Control Trial
|
N/A | |
Active, not recruiting |
NCT05843682 -
Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2
|
N/A | |
Completed |
NCT00943254 -
Metabolic Syndrome Diagnosis and Education Trial
|
N/A | |
Completed |
NCT01408667 -
Hyperinsulinemic Euglycemic Clamp Protocol
|
Phase 1/Phase 2 | |
Unknown status |
NCT01826357 -
Cluster Analysis of the Risk of Metabolic Syndrome in Women for Reproductive Age
|
N/A | |
Completed |
NCT02151227 -
Magnesium and Metabolic Syndrome: A Dose-response Meta-analysis
|
N/A | |
Completed |
NCT02460445 -
Phlebotomy and Polycystic Ovary Syndrome
|
N/A | |
Recruiting |
NCT02646475 -
Metabolic Effects of Angiotensin-(1-7)
|
Phase 1 |